This chart is based on all EMS incidents in Oregon where the patient was age 18 or under for 2022 (n = 18,811) and 2023 (n = 18,342). The graph indicates that pediatric EMS incidents primarily involve the youngest (0-4) and the oldest (15-18) age groups.
This graph is based on all EMS incidents in Oregon where the patient was age 18 or under for 2022 (n = 18,811) and 2023 (n = 18,342). Data for this chart are drawn from the ePatient.13 data element, Patient Gender, but align with EMS personnel’s assessment of patient biological sex. The composition of EMS incidents is consistent over the two years, with a greater percentage of EMS incidents involving male patients. The unknown category is a combination of missing data, “Unknown” and “Not Documented” values. In 2023, codes and descriptors for transgender patients were added to ePatient.13 in the NEMSIS 3.5 data standard. In 2023, there was only one pediatric patient care report that included a transgender code. Due to the scale of the graph, this record has been omitted because it shows up as 0%. It is anticipated that there will be a greater number of records that include transgender codes in 2024 and this will be reflected in future dashboards.
This graph is based on all EMS incidents in Oregon where the patient was age 18 or under for 2022 (n = 18,811) and 2023 (n = 18,342). Note that Race and Ethnicity are represented in NEMSIS 3.4 in a single list. All percentages are calculated as the percentage of all pediatric EMS patients for whom a particular race or ethnic category was selected. Please note that because multiple values may be selected, percentages will sum to greater than 100%.
This graph is based on all EMS incidents in Oregon where the patient was age 18 or under for 2022 (n = 18,811) and 2023 (n = 18,342). Percentages are calculated from the number of incidents in which a procedure was performed divided by the total number of incidents for each year. Please note that because more than one procedure may be performed during each EMS incident, the sum of all procedures will be greater than 100%.
This graph is based on all EMS incidents in Oregon where the patient was age 18 or under for 2022 (n = 18,811) and 2023 (n = 18,342). Percentages are calculated from the number of incidents in which the cause of injury code was reported divided by the total number of incidents for each year. Please note that because more than one cause of injury code may be reported and only the top 15 causes of injury are reported in the graph, the sum of all percentages will not be equal to 100%.
This graph is based on all EMS incidents in Oregon where the patient was age 18 or under for 2022 (n = 18,811) and 2023 (n = 18,342). Percentages are calculated from the number of incidents in which a primary impression was reported divided by the total number of incidents for each year. Please note that because only the top 15 primary impressions are reported in the graph, the sum of all percentages will be less than 100%.
This graph is based on all EMS incidents in Oregon where the patient was age 18 or under for 2022 (n = 18,811) and 2023 (n = 18,342). Percentages are calculated from the number of incidents in which a primary symptom was reported divided by the total number of incidents for each year. Please note that because only the top 15 primary symptoms are reported in the graph, the sum of all percentages will be less than 100%.
This graph is based on all EMS incidents in Oregon where patient contact was made and the patient was age 18 or under for 2022 (n = 18,811) and 2023 (n = 18,342). Percentages are calculated from the number of incidents in which a dispatch complaint was reported divided by the total number of incidents for each year. Please note that because only the top 15 complaints are reported in the graph, the sum of all percentages will be less than 100%.
NEMSQA Asthma-01 Percentage of EMS responses originating from a 911 request for patients with a diagnosis of asthma who had an aerosolized beta agonist administered.
Goal:
The goal for this metric is for 90% of patients treated by EMS for asthma to receive an aerosolized beta agonist.
Initial Population:
The population for this metric is drawn from EMS encounters in Oregon where patient contact was made with a primary or secondary impression of asthma exacerbation or acute bronchospasm. This visualization presents the pediatric subset of the population for 2022 (n = 109) and 2023 to date (n = 117). This performance measure is calculated quarterly rather than monthly due to the small number of patients treated by EMS for asthma each month. Percentages calculated from small n can be volatile as a small change in the numerator results in a large change in the metric. This volatility or “noise” can make it difficult to assess trends, and may lead to misleading interpretations.
Denominator 1:
All EMS responses in the Initial Population.
Denominator 2:
All EMS responses in the Initial Population for patients 18 years and older.
Denominator 3:
All EMS responses in the Initial Population for patients 2-18 years of age.
Numerator:
EMS responses in the denominator who had an aerosolized beta agonist administered by an EMS professional during the EMS response. Beta agonist medications may include Albuterol, Levalbuterol and Metaproterenol.
Measure specification:
NEMSQA Pediatric-03b Percentage of EMS responses originating from a 911 request for patients less than 18 years of age who received a weight-based medication and had a documented weight in kilograms or length-based weight estimate documented during the EMS response.
Goal:
The goal for this metric is for 90% of pediatric patients receiving a weight based medication to have a documented weight in kilograms in their ePCR.
Initial Population:
The population for this metric is drawn from EMS incidents in Oregon where patient contact was made and the patient was less than 18 years of age for 2022 (n = 90,740) and 2023 to date (n = 92,871).
Denominator:
All EMS responses originating from a 911 request for patients less than 18 years of age who received a weight-based medication during the EMS response.
Numerator:
EMS responses originating from a 911 request for patients in which a weight value was documented in kilograms or a length-based weight was documented during the EMS response.
Measure specification:
NEMSQA Respiratory-01 Percentage of EMS responses originating from a 911 request for patients with primary or secondary impression of respiratory distress who had a respiratory assessment.
Goal:
The goal for this metric is for 90% of patients experiencing respiratory distress to have a documented respiratory assessment.
Initial Population:
The population for this metric is all EMS encounters in Oregon where patient contact was made with a primary or secondary impression indicating respiratory distress. Respiratory distress includes impressions of Asthma, Dyspnea, Unspecified Orthopnea, shortness of breath, diagnosis of a respiratory ailment, and complaint or condition commonly associated with dyspnea. This visualization presents the pediatric subset of the population for 2022 (n = 2,040) and 2023 to date (n = 1,828).
Denominator 1:
All EMS responses in the initial population.
Denominator 2:
All EMS responses in the initial population for patients 18 or older.
Denominator 3:
All EMS responses in the initial population for patients under 18 years of age.
Numerator:
EMS encounters for patients in the denominator for whom a SpO2 and respiratory rate was taken and documented during the EMS response.
Measure specification:
NEMSQA Safety-01 Percentage of EMS responses originating from a 911 request in which lights and sirens were not used during response.
Safety-01 and Safety-02 focus on the judicious use of lights and sirens during response to scene (Safety-01) and during patient transport (Safety-02). There are strong guidelines and published studies that support the limited use of lights and sirens to protect not only the public but also EMS providers and patients from potential danger, as a consequence of lights and sirens use. The intent of these two measures is to determine how often EMS professionals are using lights and sirens during response and transport.
Goal:
The goal for this metric is for 70% of EMS 911 responses to scene to be completed without use of lights and sirens. This goal is based on expert recommendations developed by the NEMSQA Lights and Siren Collaborative national performance improvement project.
Initial Population:
Percentage of EMS responses originating from a 911 request in which lights and sirens were not used during response to the scene. This visualization presents the pediatric subset of the population for 2022 (n = 17,003) and 2023 to date (n = 16,843).
Denominator 1:
All EMS responses in the initial population.
Denominator 2:
All EMS responses in the initial population for patients 18 or older.
Denominator 3:
All EMS responses in the initial population for patients under 18 years of age.
Numerator:
EMS responses originating from a 911 request in which lights and sirens were not used.
Measure specification:
NEMSQA Safety-02 Percentage of EMS transports originating from a 911 request during which lights and sirens were not used during patient transport.
Safety-01 and Safety-02 focus on the judicious use of lights and sirens during response to scene (Safety-01) and during patient transport (Safety-02). There are strong guidelines and published studies that support the limited use of lights and sirens to protect not only the public but also EMS providers and patients from potential danger, as a consequence of lights and sirens use. The intent of these two measures is to determine how often EMS professionals are using lights and sirens during response and transport.
Goal:
The goal for this metric is for 95% of EMS transports from scene to be completed without use of lights and sirens. This goal is based on expert recommendations developed by the NEMSQA Lights and Siren Collaborative national performance improvement project.
Initial Population:
Percentage of EMS transports originating from a 911 request in which lights and sirens were not used during transport from the scene. This visualization presents the pediatric subset of the population for 2022 (n = 9,477) and 2023 to date (n = 8,633).
Denominator 1:
All EMS responses in the initial population.
Denominator 2:
All EMS responses in the initial population for patients 18 or older.
Denominator 3:
All EMS responses in the initial population for patients under 18 years of age.
Numerator:
EMS transports originating from a 911 request in which lights and sirens were not used.
Measure specification:
NEMSQA Seizure-02: Percentage of EMS responses originating from a 911 request for patients with status epilepticus who received benzodiazepine aimed at terminating their status seizure during the EMS response.
Goal:
Initial Population:
The population for this metric is all EMS responses originating from a 911 request for patients in Oregon with a primary or secondary impression indicating status epilepticus. Status epilepticus includes impressions of seizures/epilepsy with status epilepticus, epilepsy and recurrent seizures, or epilepsy that is unspecified or intractable with status epilepticus.
This visualization presents the pediatric subset of the population for 2022 (n = 231) and 2023 to date (n = 259).
Denominator 1:
All EMS responses in the initial population.
Denominator 2:
All EMS responses in the initial population for patients 18 years of age or older.
Denominator 3:
All EMS responses in the initial population for patients under 18 years of age.
Numerator:
EMS encounters for patients in the denominator who received benzodiazepine aimed at terminating their status seizure during the EMS response. Such benzodiazepine medications may include: Diazepam, Lorazepam, or Midazolam.
Measure specification: